AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG

Fontana C, Widmalm G. Primary structure of glycans by NMR Spectroscopy. Chem Rev. 2023;123:1040–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Widmalm G. Glycan shape, motions, and interactions explored by NMR Spectroscopy. JACS Au. 2024;4:20–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science. 2001;291:2364–9.

Article  CAS  PubMed  Google Scholar 

Breitling J, Aebi M. N-linked protein glycosylation in the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 2013;5:a013359.

Article  PubMed  PubMed Central  Google Scholar 

Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346–66.

Article  PubMed  PubMed Central  Google Scholar 

Varki A. Biological roles of glycans. Glycobiology. 2017;27:3–49.

Article  CAS  PubMed  Google Scholar 

Jaeken J. Congenital disorders of glycosylation. Handb Clin Neurol. 2013;113:1737–43.

Article  CAS  PubMed  Google Scholar 

Boyer SW, Johnsen C, Morava E. Nutrition interventions in congenital disorders of glycosylation. Trends Mol Med. 2022;28:463–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francisco R, Pascoal C, Marques-da-Silva D, Brasil S, Pimentel-Santos FM, Altassan R, et al. New insights into immunological involvement in Congenital Disorders of Glycosylation (CDG) from a people-centric approach. J Clin Med. 2020;9:2092.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet. 2000;8:367–71.

Article  CAS  PubMed  Google Scholar 

Altassan R, Péanne R, Jaeken J, Barone R, Bidet M, Borgel D, et al. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up. J Inherit Metab Dis. 2019;42:5–28.

Article  CAS  PubMed  Google Scholar 

Sharma V, Ichikawa M, Freeze HH. Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun. 2014;453:220–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, et al. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat. 2000;16:386–94.

Article  CAS  PubMed  Google Scholar 

Gámez A, Serrano M, Gallego D, Vilas A, Pérez B. New and potential strategies for the treatment of PMM2-CDG. Biochim Biophys Acta Gen Subj. 2020;1864:129686.

Article  PubMed  Google Scholar 

Altassan R, Witters P, Saifudeen Z, Quelhas D, Jaeken J, Levtchenko E, et al. Renal involvement in PMM2-CDG, a mini-review. Mol Genet Metab. 2018;123:292–6.

Article  CAS  PubMed  Google Scholar 

Muthusamy K, Perez-Ortiz JM, Ligezka AN, Altassan R, Johnsen C, Schultz MJ, et al. Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions. Genet Med. 2024;26:101027.

Article  CAS  PubMed  Google Scholar 

Ligezka AN, Budhraja R, Nishiyama Y, Fiesel FC, Preston G, Edmondson A, et al. Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG. Genes. 2023;14:1585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallego D, Serrano M, Cordoba-Caballero J, Gámez A, Seoane P, Perkins JR, et al. Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167163.

Article  CAS  PubMed  Google Scholar 

Radenkovic S, Ligezka AN, Mokashi SS, Driesen K, Dukes-Rimsky L, Preston G, et al. Tracer metabolomics reveals the role of aldose reductase in glycosylation. Cell Rep Med. 2023;4:101056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vilas A, Yuste-Checa P, Gallego D, Desviat LR, Ugarte M, Pérez-Cerda C, et al. Proteostasis regulators as potential rescuers of PMM2 activity. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165777.

Article  CAS  PubMed  Google Scholar 

Budhraja R, Radenkovic S, Jain A, Muffels IJJ, Ismaili MHA, Kozicz T, et al. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation. Mol Genet Metab. 2024;142:108487.

Article  CAS  PubMed  Google Scholar 

Schneider A, Thiel C, Rindermann J, DeRossi C, Popovici D, Hoffmann GF, et al. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat Med. 2011;18:71–3.

Article  PubMed  Google Scholar 

Thiel C, Lübke T, Matthijs G, von Figura K, Körner C. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol Cell Biol. 2006;26:5615–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan B, Clasquin M, Smolen GA, Histen G, Powe J, Chen Y, et al. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2. Hum Mol Genet. 2016;25:2182–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol. 2002;244:305–18.

Article  CAS  PubMed  Google Scholar 

Balakrishnan B, Yan X, McCue MD, Bellagamba O, Guo A, Winkler F, et al. Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia. Mol Ther Methods Clin Dev. 2024;32:101191.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29:52.

Article  CAS  PubMed  Google Scholar 

Balakrishnan B, Verheijen J, Lupo A, Raymond K, Turgeon C, Yang Y, et al. A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality. J Inherit Metab Dis. 2019;42:998–1007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. Journal of visualized experiments : JoVE. 2010:1787.

Kim BW, Jeong KH, Kim JH, Jin M, Kim JH, Lee MG, et al. Pathogenic upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System. J Neurosci. 2016;36:5608–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, et al. Avoidance of

Comments (0)

No login
gif